Kilitch Drugs (India) Ltd Performance
Day's Low
Day's High
₹315.6₹33052 Week's Low
52 Week's High
₹300₹470
| Returns % | |
| 1 Month Return | -2.44 % |
| 3 Month Return | -16.02 % |
| 1 Year Return | -2.92 % |
| Market Stats | |
| Previous Close | ₹323.20 |
| Open | ₹323.25 |
| Volume | 5,260.00 |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹519.78Cr |
Kilitch Drugs (India) Ltd Key Statistics
| P/E Ratio | 31.7 |
| PEG Ratio | 22.81 |
| Market Cap | ₹519.78 Cr |
| P/B Ratio | 2.81 |
| EPS | 8.44 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 8.39 |
Kilitch Drugs (India) Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹519.78 Cr | 34.09% | 0.56 | ₹13 Cr | ₹154 Cr | |
| NA | ₹1,106.97 Cr | 49.64% | 0.51 | NA | NA | |
| NA | ₹159.73 Cr | 164.07% | 2.00 | ₹14 Cr | ₹502 Cr | |
| NA | ₹1,171.88 Cr | 0.32% | 0.56 | ₹41 Cr | ₹338 Cr | |
| NA | ₹4,365.08 Cr | 117.67% | 0.70 | ₹86 Cr | ₹806 Cr |
About Kilitch Drugs (India) Ltd
Share Price: ₹325.90 per share as on 13 Dec, 2024 04:01 PM
Market Capitalisation: ₹519.78Cr as of today
Revenue: ₹47.47Cr as on September 2024 (Q3 24)
Net Profit: ₹8.61Cr as on September 2024 (Q3 24)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
| Organisation | Kilitch Drugs (India) Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Kilitch Drugs (India) Ltd
Kilitch Drugs Reports Strong Q2 Growth in Sales and Profit - 28 Nov, 2024
Kilitch Drugs reported a 15.22% increase in net sales to Rs 47.47 crore for September 2024, with net profit rising 81.75% to Rs 8.62 crore. EBITDA also grew by 23.6%. However, shares have declined by 6.69% over the last six months.
Insights on Kilitch Drugs (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 1.34 Cr → 8.62 Cr (in ₹), with an average increase of 84.5% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 36.03 Cr → 52.64 Cr (in ₹), with an average increase of 31.6% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 69.23% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 136.8% return, outperforming this stock by 51.0%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.8% return, outperforming this stock by 68.4%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 30.77% to 30.76% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, KILITCH stock has moved down by -4.1%
Kilitch Drugs (India) Ltd Financials
Kilitch Drugs (India) Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 69.23% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 30.76% | ||
| Others | 0% | 0.00 |
Kilitch Drugs (India) Ltd Key Indicators
Kilitch Drugs (India) Ltd Valuation
Kilitch Drugs (India) Ltd in the last 5 years
Lowest (-986.00x)
July 3, 2019
Today (31.70x)
December 13, 2024
Industry (56.50x)
December 13, 2024
Highest (363.79x)
October 16, 2020
Kilitch Drugs (India) Ltd Earnings and Dividends
Kilitch Drugs (India) Ltd Earnings Results
Kilitch Drugs (India) Ltd’s net profit jumped 81.86% since last year same period to ₹8.62Cr in the Q2 2024-2025. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated 543.28% jump in its net profits since last 3-months.
Read More about Earnings ResultsKilitch Drugs (India) Ltd Dividends May,2019
In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.15%.
Read More about Dividends
Kilitch Drugs (India) Ltd Technicals Summary
Bearish
Neutral
Bullish
Kilitch Drugs (India) Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Kilitch Drugs (India) Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Kilitch Drugs (India) Ltd shares.
Kilitch Drugs (India) Ltd (KILITCH) share price today is ₹325.9
Kilitch Drugs (India) Ltd is listed on NSE
Kilitch Drugs (India) Ltd is listed on BSE
- Today’s highest price of Kilitch Drugs (India) Ltd is ₹330.
- Today’s lowest price of Kilitch Drugs (India) Ltd is ₹315.6.
PE Ratio of Kilitch Drugs (India) Ltd is 31.7
PE ratio = Kilitch Drugs (India) Ltd Market price per share / Kilitch Drugs (India) Ltd Earnings per share
Today’s traded volume of Kilitch Drugs (India) Ltd(KILITCH) is 5,260.00.
Today’s market capitalisation of Kilitch Drugs (India) Ltd(KILITCH) is ₹519.78Cr.
| Kilitch Drugs (India) Ltd(KILITCH | Price |
|---|---|
52 Week High | ₹470 |
52 Week Low | ₹300 |
Kilitch Drugs (India) Ltd(KILITCH) share price is ₹325.9. It is down -30.66% from its 52 Week High price of ₹470
Kilitch Drugs (India) Ltd(KILITCH) share price is ₹325.9. It is up 8.63% from its 52 Week Low price of ₹300
| Kilitch Drugs (India) Ltd(KILITCH | Returns |
|---|---|
1 Day Returns | 2.7% |
1 Month Returns | -2.44% |
3 Month Returns | -16.02% |
1 Year Returns | -2.92% |